Stage I Prostate Cancer Terminated Phase 2 Trials for Cabazitaxel (DB06772)

Also known as: Prostate cancer stage I / Carcinoma of the prostate stage I / Prostatic cancer stage I

IndicationStatusPhase
DBCOND0028877 (Stage I Prostate Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01469338Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With DocetaxelSupportive Care